We reassessed renal biopsy specimens from 116 patients with systemic lupus erythematosus and clinical manifestations of lupus nephritis to determine the contributions of the World Health Organization classification system, the activity and chronicity indexes of the National Institutes of Health scor
β¦ LIBER β¦
Retrospective analysis of the renal outcome of pediatric lupus nephritis
β Scribed by Li-Chieh Wang; Yao-Hsu Yang; Meng-Yao Lu; Bor-Luen Chiang
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 208 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Contribution of renal biopsy data in pre
Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients
β
Hans C. Nossent; Sonja C. Henzen-Logmans; Thea M. Vroom; Jo H. M. Berden; Tom J.
π
Article
π
1990
π
John Wiley and Sons
π
English
β 647 KB
Outcomes of children with proliferative
β
David Askenazi; Barry Myones; Ankur Kamdar; Robert Warren; Maria Perez; Marietta
π
Article
π
2007
π
Springer
π
English
β 179 KB
The value of the renal biopsy in lupus n
β
Robert T. Mccluskey
π
Article
π
1982
π
John Wiley and Sons
π
English
β 939 KB
Comprehensive analysis of microRNA expre
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients
β
Yong Dai; Weiguo Sui; Huijuan Lan; Qiang Yan; He Huang; YuanShuai Huang
π
Article
π
2008
π
Springer
π
English
β 291 KB
Analysis of clinical manifestations and
β
Qiaoyan Guo; Xuehong Lu; Lining Miao; Man Wu; Shan Lu; Ping Luo
π
Article
π
2010
π
Springer
π
English
β 118 KB
Early response to immunosuppressive ther
β
FrΓ©dΓ©ric A. Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani
π
Article
π
2004
π
John Wiley and Sons
π
English
β 82 KB
π 2 views
## Abstract ## Objective In the EuroβLupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were randomly assigned to a highβdose intravenous cyclophosphamide (IV CYC) regimen (6 monthly pulses and 2 quarterly pulses with escalating doses) or a lowβdose IV CYC regimen (6 pulses of 500 mg g